Hanneke Schuitemaker

30.4k citations

273 papers · 13.4k indexed · 4 hit papers · h-index 63

Impact in

Virology top 0.01%
- HIV Research and Treatment
Infectious Diseases top 0.05%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 224
- HIV Research and Treatment 223
Infectious Diseases 183
- HIV/AIDS drug development and treatment 121
- HIV/AIDS Research and Interventions 89
- Viral gastroenteritis research and epidemiology 23

Co-authors: Frank Miedema Neeltje A. Kootstra Angélique B. van ’t Wout M Tersmette Ron A. M. Fouchier Margreet Brouwer Hetty Blaak Joep M. A. Lange
Journals: Journal of Virology (39 papers)AIDS (30 papers)The Journal of Infectious Diseases (24 papers)Virology (17 papers)PLoS ONE (15 papers)
Partner nations: Netherlands United States Belgium

In The Last Decade

Hanneke Schuitemaker

268 papers receiving 13.1k citations

Hit Papers

align trajectories log scale

Complex-type N -glycan recognition by potent broadly neutralizing HIV antibodies 2012 · 400 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Proceedings of the National Academy of Sciences
1995 The Journal of Experimental Medicine
1992 Journal of Virology
1992 Journal of Virology

Peers

Countries citing papers authored by Hanneke Schuitemaker

Since Specialization

Citations

This map shows the geographic impact of Hanneke Schuitemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanneke Schuitemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanneke Schuitemaker more than expected).

Fields of papers citing papers by Hanneke Schuitemaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanneke Schuitemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanneke Schuitemaker. The network helps show where Hanneke Schuitemaker may publish in the future.

Co-authors

The 25 scholars most cited alongside Hanneke Schuitemaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hanneke Schuitemaker Line = papers co-authored together Hanneke Schuitemaker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits Nature Communications ·Annemart Koornneef, Kanika Vanshylla, Gijs Hardenberg, Lucy Rutten, Nika M. Strokappe, Jeroen Tolboom, Jessica Vreugdenhil, Karin Feddes-de Boer, Aditya Perkasa, Sven Blokland, Judith A. Burger, Wei‐Chiao Huang, Jonathan F. Lovell, Daniëlle van Manen, Rogier W. Sanders, Roland Zahn, Hanneke Schuitemaker, Johannes P. M. Langedijk, Frank Wegmann	2024	4
2	Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial Vaccine ·Mathieu Le Gars, Jerald Sadoff, Vicky Cárdenas, Dirk Heerwegh, Fisseha Tesfaye, Griet Van Roey, C. C. Spicer, Samantha Santoro Matias, Olivia Crayne, Tobias Kamphuis, Frank Struyf, Hanneke Schuitemaker, Macaya Douoguih	2024	0
3	Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models npj Vaccines ·Eiríkur Saeland, Leslie van der Fits, Renske Bolder, Marjolein Heemskerk-van der Meer, Joke Drijver, Yolinda van Polanen, Cornelis Vaneman, Lisanne Tettero, Freek Cox, Jan Serroyen, Matthew J. Jorgensen, Johannes P. M. Langedijk, Hanneke Schuitemaker, Benoît Callendret, Roland Zahn	2023	11
4	A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials Science Translational Medicine ·Philip K. Ehrenberg, Shida Shangguan, Biju Issac, Galit Alter, Aviva Geretz, T Izumi, Christopher Bryant, Michael A. Eller, Frank Wegmann, Richard Apps, Matthew Creegan, Diane L. Bolton, Rafick‐Pierre Sékaly, Merlin L. Robb, Robert Gramzinski, Maria Grazia Pau, Hanneke Schuitemaker, Dan H. Barouch, Nelson L. Michael, Rasmi Thomas	2019	17
5	Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses Vaccine ·Marija Vujadinovic, Selina Khan, Koen Oosterhuis, Taco G. Uil, Kerstin Wunderlich, Sarra Damman, Satish Boedhoe, Annemiek Verwilligen, Jonathan Knibbe, Jan Serroyen, Hanneke Schuitemaker, Roland Zahn, Gert C. Scheper, Jerome Custers, Jort Vellinga	2018	18
6	Evolution of Human Immunodeficiency Virus Type 1 in a Patient with Cross-Reactive Neutralizing Activity in Serum Journal of Virology ·Marit J. van Gils, Diana Edo-Matas, Emma J. Bowles, Judith A. Burger, Guillaume B. E. Stewart-Jones, Hanneke Schuitemaker	2011	7
7	Immunization with Recombinant HLA Classes I and II, HIV-1 gp140, and SIV p27 Elicits Protection against Heterologous SHIV Infection in Rhesus Macaques Journal of Virology ·Andreas Mörner, Marianne Jansson, Evelien M. Bunnik, Jørgen Schøller, R. S. Vaughan, Yufei Wang, David C. Montefiori, Ńel Otting, Ronald E. Bontrop, Lesley A. Bergmeier, Mahavir Singh, Richard T. Wyatt, Hanneke Schuitemaker, Gunnel Biberfeld, Rigmor Thorstensson, Thomas Lehner	2011	14
8	The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor–recipient pair Virology ·Diana Edo-Matas, Andrea Rachinger, Laurentia C. Setiawan, Brigitte Boeser‐Nunnink, Angélique B. van ’t Wout, Philippe Lemey, Hanneke Schuitemaker	2011	11
9	Low Incidence of HIV-1 Superinfection Even After Episodes of Unsafe Sexual Behavior of Homosexual Men in the Amsterdam Cohort Studies on HIV Infection and AIDS The Journal of Infectious Diseases ·Andrea Rachinger, Precious Manyenga, Judith A. Burger, Tom L. P. Derks van de Ven, Ineke G. Stolte, Maria Prins, Angélique B. van ’t Wout, Hanneke Schuitemaker	2011	12
10	Clinical significance of HIV-1 coreceptor usage Journal of Translational Medicine ·Hanneke Schuitemaker, Angélique B. van ’t Wout, Paolo Lusso	2011	75
11	Absence of HIV‐1 Superinfection 1 Year after Infection between 1985 and 1997 Coincides with a Reduction in Sexual Risk Behavior in the Seroincident Amsterdam Cohort of Homosexual Men Clinical Infectious Diseases ·Andrea Rachinger, Ineke G. Stolte, Tom Derks van de Ven, Judith A. Burger, Maria Prins, Hanneke Schuitemaker, Angélique B. van ’t Wout	2010	18
12	Autologous Neutralizing Humoral Immunity and Evolution of the Viral Envelope in the Course of Subtype B Human Immunodeficiency Virus Type 1 Infection Journal of Virology ·Evelien M. Bunnik, Linaida Pisas, Ad C. van Nuenen, Hanneke Schuitemaker	2008	134
13	Low Immune Activation despite High Levels of Pathogenic Human Immunodeficiency Virus Type 1 Results in Long-Term Asymptomatic Disease Journal of Virology ·Shailesh K. Choudhary, Nienke Vrisekoop, Christine A. Jansen, Sigrid A. Otto, Hanneke Schuitemaker, Frank Miedema, David Camerini	2007	75
14	T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates Virology ·Esther D. Quakkelaar, Tim Beaumont, Ad C. van Nuenen, Floris P. J. van Alphen, Brigitte Boeser‐Nunnink, Angélique B. van ’t Wout, Hanneke Schuitemaker	2006	7
15	Natural controlled HIV infection: Preserved HIV-specific immunity despite undetectable replication competent virus Virology ·Nico Kloosterboer, P. H. P. Groeneveld, Christine A. Jansen, Teun J. K. van der Vorst, Frits Koning, Carel N. Winkel, Ashley J. Duits, Frank Miedema, Debbie van Baarle, Ronald P. van Rij, Kees Brinkman, Hanneke Schuitemaker	2005	24
16	GB Virus C Coinfection and HIV‐1 Disease Progression: The Amsterdam Cohort Study The Journal of Infectious Diseases ·Akke K. van der Bij, Nico Kloosterboer, Maria Prins, Brigitte Boeser‐Nunnink, Ronald B. Geskus, Joep MA Lange, R A Coutinho, Hanneke Schuitemaker	2005	65
17	Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression AIDS ·Stephanie A. Mulherin, Thomas R. OʼBrien, John P. A. Ioannidis, James J. Goedert, Susan Buchbinder, Roel A. Coutinho, Beth D. Jamieson, Laurence Meyer, Nelson L. Michael, Giuseppe Pantaleo, G. Paolo Rizzardi, Hanneke Schuitemaker, Haynes W. Sheppard, Ioannis Theodorou, David Vlahov, Philip S. Rosenberg	2003	78
18	Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells AIDS ·Annapurna Vyakarnam, Josiah Eyeson, Ian Teo, Mark Zuckerman, Kaboutar Babaahmady, Hanneke Schuitemaker, Sunil Shaunak, Timothy Rostron, Sarah Rowland‐Jones, Graham Simmons, Paul R. Clapham	2001	10
19	Early Replication Steps but Not Cell Type-Specific Signalling of the Viral Long Terminal Repeat Determine HIV-1 Monocytotropism AIDS Research and Human Retroviruses ·Hanneke Schuitemaker, M Groenink, Linde Meyaard, Neeltje A. Kootstra, Ron A. M. Fouchier, Rob A. Gruters, Han G. Huisman, Matthijs Tersmette, Frank Miedema	1993	13
20	Differential Tropism of Clinical HIV-1 Isolates for Primary Monocytes and Promonocytic Cell Lines AIDS Research and Human Retroviruses ·Hanneke Schuitemaker, Neeltje A. Kootstra, M Groenink, R. E. Y. de Goede, Frank Miedema, Matthijs Tersmette	1992	26

About Hanneke Schuitemaker

Hanneke Schuitemaker is a scholar working on Virology, Infectious Diseases, Immunology, Emergency Medicine and Epidemiology, having authored 273 papers that have together received 13.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (223 papers), HIV/AIDS drug development and treatment (121 papers), Immune Cell Function and Interaction (96 papers), HIV/AIDS Research and Interventions (89 papers), T-cell and B-cell Immunology (27 papers), Viral gastroenteritis research and epidemiology (23 papers), Virus-based gene therapy research (18 papers) and HIV-related health complications and treatments (16 papers). The work is most often cited by research in Virology (10.6k citations), Infectious Diseases (6.9k citations), Immunology (5.8k citations), Epidemiology (2.8k citations) and Emergency Medicine (673 citations). Hanneke Schuitemaker has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Frank Miedema, Neeltje A. Kootstra, Angélique B. van ’t Wout, M Tersmette, Ron A. M. Fouchier, Margreet Brouwer, Hetty Blaak, Joep M. A. Lange, R E de Goede and Silvia Broersen. Their work appears in journals such as Journal of Virology, AIDS, The Journal of Infectious Diseases, Virology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact